Recommendations for the Diagnosis and Management of Asbestos-Related Pleural and Pulmonary Disease

Carmen Diego Roza; M Jesús Cruz Carmona; Ramón Fernández Álvarez; Jaume Ferrer Sancho; Belén Marín Martínez; Cristina Martínez González; José Antonio Rodríguez Portal; Fernando Romero Valero; Victoria Villena Garrido

doi:10.1016/j.arbres.2016.12.014

Recommendations for the Diagnosis and Management of Asbestos-Related Pleural and Pulmonary Disease

Arch Bronconeumol. 2017 Aug;53(8):437-442. doi: 10.1016/j.arbres.2016.12.014. Epub 2017 Mar 6.

[Article in English, Spanish]

Authors

Carmen Diego Roza¹, M Jesús Cruz Carmona², Ramón Fernández Álvarez³, Jaume Ferrer Sancho², Belén Marín Martínez⁴, Cristina Martínez González³, José Antonio Rodríguez Portal⁵, Fernando Romero Valero⁶, Victoria Villena Garrido⁷

Affiliations

¹ Complexo Hospitalario Universitario de Ferrol, La Coruña, España. Electronic address: [email protected].
² Hospital Val d'Hebrón, Barcelona, España.
³ Hospital Universitario Central de Asturias, Oviedo, España.
⁴ Complejo Hospitalario de Navarra, Pamplona, España.
⁵ Hospital Universitario Virgen del Rocío, Sevilla, España.
⁶ Hospital Universitario Puerta del Mar, Cádiz, España.
⁷ Hospital Universitario 12 de Octubre, Madrid, España.

PMID: 28279517
DOI: 10.1016/j.arbres.2016.12.014

Abstract

Asbestos is the term used for a set of mineral silicates that tend to break up into fibers. Its use has been associated with numerous diseases affecting the lung and pleura in particular, all of which are characterized by their long period of latency. Asbestos, moreover, has been recognized by the WHO as a Group IA carcinogen since 1987 and its use was banned in Spain in 2002. The publication in 2013 of the 3rd edition of the specific asbestos health monitoring protocol, together with the development of new diagnostic techniques, prompted the SEPAR EROM group to sponsor publication of guidelines, which review the clinical, radiological and functional aspects of the different asbestos-related diseases. Recommendations have also been made for the diagnosis and follow-up of exposed patients. These recommendations were drawn up in accordance with the GRADE classification system.

Keywords: Asbesto; Asbestos; Cancer; Cáncer; Mesotelioma; Mesothelioma; Pleura.

Publication types

Practice Guideline

MeSH terms

Asbestos / classification
Asbestos / toxicity
Asbestosis / diagnosis*
Asbestosis / diagnostic imaging
Asbestosis / prevention & control
Asbestosis / therapy*
Biomarkers, Tumor
Carcinoma, Bronchogenic / diagnosis
Carcinoma, Bronchogenic / etiology
Carcinoma, Bronchogenic / therapy
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / etiology
Lung Neoplasms / therapy
Mass Screening
Mesothelioma / diagnosis
Mesothelioma / etiology
Mesothelioma / therapy
Mineral Fibers / analysis
Mineral Fibers / toxicity
Occupational Exposure
Occupational Health / legislation & jurisprudence
Pleural Diseases / diagnosis
Pleural Diseases / diagnostic imaging
Pleural Diseases / therapy
Pleural Neoplasms / diagnosis
Pleural Neoplasms / etiology
Pleural Neoplasms / therapy
Positron Emission Tomography Computed Tomography
Respiratory Function Tests
Smoking / epidemiology
Spain

Substances

Biomarkers, Tumor
Mineral Fibers
Asbestos